Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership225,051 shares
Latest Disclosed Value $ 29,648,218
Prudential Financial Inc reports 74.22% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 225,051 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $29,648,218 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 129,178 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 74.22% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 225,051 95,873 74.22 29,648 61.83 0.0205
2026-02-13 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 129,178 26,330 25.60 18,321 26.90 0.0221
2025-11-13 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 102,848 -42,482 -29.23 14,438 -18.88 0.0172
2025-08-12 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 145,330 26,030 21.82 17,798 31.52 0.0230
2025-05-13 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 119,300 -90,875 -43.24 13,533 -46.11 0.0193
2025-02-11 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 210,175 33,450 18.93 25,112 23.32 0.0344
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 176,725 -17,529 -9.02 20,362 -23.86 0.0287
2024-08-13 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 194,254 78,136 67.29 26,743 66.98 0.0402
2024-05-14 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 116,118 -213,253 -64.75 16,015 -63.10 0.0225
2024-02-13 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 329,371 50,204 17.98 43,398 37.61 0.0656
2023-11-13 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 279,167 193,117 224.42 31,536 288.66 0.0495
2023-08-11 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 86,050 21,980 34.31 8,115 26.74 0.0118
2023-05-12 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 64,070 9,193 16.75 6,403 -2.32 0.0100
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 54,877 5,227 10.53 6,555 27.26 0.0110
2022-11-04 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 49,650 19,991 67.40 5,150 77.22 0.0087
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 29,659 -31,192 -51.26 2,906 -49.06 0.0046
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 60,851 38,962 178.00 5,705 181.03 0.0076
2022-02-14 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,889 4,096 23.02 2,030 18.23 0.0025
2021-11-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 17,793 -5,530 -23.71 1,717 -24.36 0.0024
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,323 -15,208 -39.47 2,270 -39.42 0.0031
2021-05-12 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 38,531 -28,016 -42.10 3,747 -41.26 0.0056
2021-08-16 2020-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 0095 64125C109 66,547 64,186 2,718.59 6,379 2,710.13 0.0107
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 66,547 64,186 6,379 0.0107
2021-08-05 2020-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 2,361 274 13.13 227 -10.98 0.0328
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 77,742 75,655 7,476 0.0141
2021-08-05 2020-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 0122 64125C109 2,087 193 10.19 255 55.49 0.0472
2020-08-12 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 89,543 87,649 10,925 0.0210
2021-08-05 2020-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 0086 64125C109 1,894 481 34.04 164 7.89 0.0426
2020-05-12 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 54,163 52,750 4,688 0.0104
2021-08-05 2019-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 0107 64125C109 1,413 9 0.64 152 19.69 0.0396
2020-02-11 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 44,031 42,627 4,733 0.0070
2021-08-05 2019-09-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 0090 64125C109 1,404 152 12.14 127 19.81 0.0415
2019-11-13 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 42,870 41,618 3,863 0.0061
2021-08-05 2019-06-30 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 1,252 48 3.99 106 0.00 0.0368
2019-08-08 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,270 7,066 698 0.0011
2021-08-05 2019-03-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 1,204 851 241.08 106 324.00 0.0450
2019-05-15 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,520 12,167 1,103 0.0018
2021-08-05 2018-12-31 13F/A-1 NEUROCRINE BIOSCIENCES COM 64125C109 353 -26,107 -98.67 25 -99.23 0.0202
2019-02-07 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,120 -340 1,865 0.0033
2018-11-07 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 26,460 21,890 478.99 3,253 624.50 0.0048
2018-08-13 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,570 0 0.00 449 18.47 0.0007
2018-05-04 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,570 0 0.00 379 6.76 0.0006
2018-02-13 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,570 -700 -13.28 355 9.91 0.0005
2017-11-02 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,270 0 0.00 323 33.47 0.0005
2017-08-07 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,270 -172,200 -97.03 242 -96.85 0.0004
2017-05-10 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 177,470 -62,700 -26.11 7,684 -17.33 0.0120
2017-02-07 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 240,170 8,357 3.61 9,295 -20.83 0.0149
2016-11-04 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 231,813 -32,850 -12.41 11,740 -2.40 0.0194
2016-08-09 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 264,663 -522 -0.20 12,029 14.69 0.0202
2016-05-09 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 265,185 177,088 201.01 10,488 110.43 0.0188
2016-02-12 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 88,097 0 0.00 4,984 42.20 0.0090
2015-11-10 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 88,097 170 0.19 3,505 -16.53 0.0069
2015-08-06 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 87,927 0 0.00 4,199 20.25 0.0075
2015-05-01 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 87,927 200 0.23 3,492 78.16 0.0061
2015-02-06 2014-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 87,727 -900 -1.02 1,960 41.11 0.0036
2014-11-12 2014-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 88,627 -8,477 -8.73 1,389 -3.61 0.0026
2014-08-13 2014-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 97,104 8,377 9.44 1,441 0.84 0.0025
2014-05-14 2014-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 88,727 400 0.45 1,429 73.21 0.0027
2014-02-11 2013-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 88,327 -300 -0.34 825 -17.75 0.0016
2013-11-07 2013-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 88,627 -38,600 -30.34 1,003 -41.07 0.0021
2013-08-07 2013-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 127,227 127,227 1,702 0.0038
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.